Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form, in dosage forms and in the presence of its oxidative degradates

被引:25
作者
Amin, AS [1 ]
Ahmed, IS [1 ]
Dessouki, HA [1 ]
Gouda, EA [1 ]
机构
[1] Benha Univ, Fac Sci, Dept Chem, Banha, Egypt
关键词
spectrophotometry; oxidation reaction; ranitidine HCl; N-bromosuccinimide; cerium(IV) sulfate; dosage forms;
D O I
10.1016/S1386-1425(02)00226-3
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Three simple, accurate and sensitive colorimetric methods (A, B and C) for the determination of ranitidine HCl (RHCl) in bulk sample, in dosage forms and in the presence of its oxidative degradates are described. The first method A is based on the oxidation of the drug by N-bromosuccinimide (NBS) and determination of the unreacted NBS by measurement of the decrease in absorbance of amaranth dye (AM) at a suitable lambda(max) = 520 nm. The methods B and C involve the addition of excess Ce4+ and determination of the unreacted oxidant by decrease the red color of chromotrope 2R (C2R) at a suitable lambda(max) = 528 nm for method B or decrease the orange pink color of rhodamine 6G (Rh6G) at a suitable lambda(max) = 526 nm for method C. Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges 0.2-3.6, 0.1-2.8 and 0.1-2.6 mug ml(-1) for methods A, B and C, respectively. The apparent molar absorptivity. Sandell sensitivity, detection and quantitation limits were calculated. For more accurate results, Ringbom optimum concentration ranges were 0.3-3.4, 0.2-2.6 and 0.2-2.4 mug ml(-1) for methods A, B and C, respectively. Analyzing pure and dosage forms containing RHCl tested the validity of the proposed methods. The relative standard deviations were less than or equal to1.38 with recoveries 98.9-101.0%. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:695 / 703
页数:9
相关论文
共 33 条
[1]   DETERMINATION OF RANITIDINE IN A BIOLOGICAL-MATERIAL BY USING DIFFERENTIAL PULSE ADSORPTIVE STRIPPING VOLTAMMETRY [J].
ALTINOZ, S ;
OZER, D ;
TEMIZER, A ;
BAYRAKTAR, Y .
ANALYTICAL LETTERS, 1992, 25 (01) :111-118
[2]  
[Anonymous], 1978, SPECTROCHIM ACTA, VB33, P242
[3]  
[Anonymous], ANAL LETT
[4]  
ATKOSAR Z, 1989, ACTA PHARM TURC, V31, P139
[5]   Spectrophotometric determination of certain cephalosporins through oxidation with cerium(IV) and 1-chlorobenzotriazole [J].
Ayad, MM ;
Shalaby, AA ;
Abdellatef, HE ;
Elsaid, HM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 20 (03) :557-564
[6]   Stability indicating spectrodensitometric determination of ranitidine hydrochloride using linear and non-linear regression [J].
El-Bayoumi, AEA ;
El-Shanawany, A ;
El-Sadek, ME ;
El-Sattar, AA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (04) :867-873
[7]  
Emmanuel J, 1989, INDIAN DRUGS, V26, P249
[8]   Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography [J].
Farthing, D ;
Brouwer, KLR ;
Fakhry, I ;
Sica, D .
JOURNAL OF CHROMATOGRAPHY B, 1997, 688 (02) :350-353
[9]   Determination of ranitidine in pharmaceutical preparations using manual and flow injection potentiometry and spectrophotometry [J].
Hassan, SSM ;
Mahmoud, WH ;
Othman, AHM .
ANALYTICA CHIMICA ACTA, 1996, 332 (01) :39-48
[10]   Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products [J].
Ho, C ;
Huang, HM ;
Hsu, SY ;
Shaw, CY ;
Chang, BL .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (03) :379-385